SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is experiencing a historic surge driven by a relentless short squeeze and a significant China silver export ban, sparking intense euphoria and FOMO within the community. Discussions are polarizing between those forecasting substantial new highs and others cautioning about a potential "bubble" or "rug pull," drawing comparisons to past spectacular rallies like Bitcoin and GME. This momentum is further amplified by broader concerns over economic instability, dollar weakness, and silver's re-evaluated role as a critical safe-haven and industrial asset.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp (UAMY) is gaining significant attention following its acquisition of a critical minerals flotation facility, further solidifying its vertical integration. Investors are keenly discussing the company's unique position as the sole US antimony producer for military applications, speculating on potential government investments and a short squeeze. This renewed interest is fueled by a broader focus on securing domestic critical mineral supply chains and recent institutional activity, including a notable share purchase by the State of Alaska.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as reports indicate a significant $1.6 billion US government investment, including a 10% equity stake and debt financing, aimed at bolstering domestic critical mineral production. This news has triggered an overnight trading halt and fueled highly bullish community sentiment, with many anticipating a substantial short squeeze and new all-time highs. Investors see this as a strategic 'America First' move in a hot rare earth sector, reinforcing supply chain security.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is hitting unprecedented record highs, fueling intense community discussion on whether this represents a fundamental shift towards safe-haven assets amidst global uncertainty and dollar weakness, or an overheated, speculative frenzy. Sentiment is sharply divided between those expecting continued strength from central bank diversification and others anticipating a significant market correction after such a rapid ascent.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. is experiencing a significant short squeeze, fueled by a recent AI-related deal and an extremely low float. The community is actively debating its parabolic run, with many anticipating continued upward momentum reminiscent of past volatile stock surges, while others warn of extreme volatility and potential risks. This explosive price action has drawn broad attention, especially given the current interest in AI sector plays.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver (AG) is a hot topic as the community buzzes about the unprecedented surge in silver prices, widely seen as heading towards "triple digits" amid physical shortages and de-dollarization narratives. Despite this historic metal rally, many are debating why AG's stock has lagged, with strong expectations for a significant catch-up given the company's record production and recent dividend increase.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines faces market volatility following reports that acquisition talks with a major pharmaceutical company concluded without an agreement on price. Despite the immediate reaction, investors are actively debating the long-term value of RVMD's promising oncology pipeline for RAS-addicted cancers, with many speculating about potential interest from other suitors in a competitive biotech M&A environment.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending due to its highly engaged and dedicated community, which is passionately building a 'permissionless brand' with numerous real-world products and initiatives. The community actively highlights their consistent efforts in developing a diverse ecosystem, from spices to entertainment, emphasizing long-term organic growth and an undervalued status across multiple blockchains.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending due to strong Glioblastoma trial data, with median overall survival not yet reached, alongside recent Saudi approvals for lung cancer that significantly expand its global market. The community is actively discussing the potential for a substantial short squeeze, fueled by high short interest and anticipation of further positive news regarding its broad-spectrum Anktiva platform, a "chemo-free" immunotherapy seen as a paradigm shift in cancer treatment.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending with high anticipation for a new piece on the stock from investor Michael Burry, expected early this week, alongside recent share accumulation by Ryan Cohen. The community is buzzing with speculation about a potential short squeeze and a Roaring Kitty return, while also voicing concerns over perceived market manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NGEN Boxing Day. Looking forward to not having to worry if TSX is open and seeing today’s volume cross the tape in minutes, not hours!

John Doe

Tim The Enchanter

Steven Craig

Chris DeLellis

David Bonanno

Tomas bermejo

Karl Kozulka

Erin Pille

Matthew McCormack

Magirus

StockTwits Web

NervGen Pharma Corp

$NGENF Boxing Day. Looking forward to not having to worry if TSX is open and seeing today’s volume cross the tape in minutes, not hours!

Lineage Cell Therapeutics Inc

Capricor Therapeutics Inc

FS KKR Capital Corp

Blackstone Secured Lending Fund

@aladdinscarpet

Agreed 👍. When you mentioned 5-15 business days, were you talking from the time you originally posted or 5-15 from when the EFFECT gets posted?

StockTwits for iOS



Agreed 👍. When you mentioned 5-15 business days, were you talking from the time you originally posted or 5-15 from when the EFFECT gets posted?

Johnson & Johnson

Pfizer Inc

Abbvie Inc

@MetalinMaybach 5-15 after Christmas eve. It’s an educated guess based on uplisting process, but we are closer to the end. Makes sense if they applied in mid-late November then that would be a total of 7-8 weeks which is normal. I expect more info (F-10/A or effectiveness announcement) by latest Jan. 9th. Then the first day of trading depends on how the financing will shape up. There some benefit to the transition being complete by Jan. 16th, corresponding to the end of the JP Morgan Healthcare Conference. We would expect to see high insti interest and (hopefully) sector rotation but all of that is TBD. There are a range of outcomes but a novel broad neuro phase 3 asset is worth at least $3B which is more than 6x today’s fully diluted MC (assuming all warrants and options exercised). If aa opens up it’s double that, and double or more if aa is granted 12-16 months from now. All we have to do is a) buy more and b) wait. Doing nothing is probably the hardest single thing to do as an investor and, if the investment thesis is correct, often the most profitable.

Riley Martin

Andrew Commons

Broc Segura

 5-15 after Christmas eve. It’s an educated guess based on uplisting process, but we are closer to the end. Makes sense if they applied in mid-late November then that would be a total of 7-8 weeks which is normal. I expect more info (F-10/A or effectiveness announcement) by latest Jan. 9th. Then the first day of trading depends on how the financing will shape up. There some benefit to the transition being complete by Jan. 16th, corresponding to the end of the JP Morgan Healthcare Conference. We would expect to see high insti interest and (hopefully) sector rotation but all of that is TBD. There are a range of outcomes but a novel broad neuro phase 3 asset is worth at least $3B which is more than 6x today’s fully diluted MC (assuming all warrants and options exercised). If aa opens up it’s double that, and double or more if aa is granted 12-16 months from now. All we have to do is a) buy more and b) wait. Doing nothing is probably the hardest single thing to do as an investor and, if the investment thesis is correct, often the most profitable.